Trastuzumab Deruxtecan – March 2026

Powder for I.V. infusion 100 mg

  • Brand names:
    • Enhertu®
  • Pharmaceutical Company:
    • ASTRAZENECA PTY LTD
  • Condition/Indication: Breast cancer
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026